Hedge Fund Boone Capital Stake in HealthEquity: Is It a Buy?
Boone Capital just disclosed a fresh position in HealthEquity, raising questions about the stock's potential. This gu...
Identify the mistake, adjust your plan, and implement corrective habits. This concise guide gives actionable steps to recover quickly and stay on track.
18,261 articlesBoone Capital just disclosed a fresh position in HealthEquity, raising questions about the stock's potential. This gu...
Tech stocks lead early gains as oil eases and AI developments grab attention. The live Nasdaq Composite shows tech st...
Ethereum’s chart flashed a buy signal after months of pressure, with prices hovering near the $2,320–$2,360 range as ...
XRP punched through a key resistance level and is eyeing a higher target as bulls regain control. Here’s what’s fueli...
A seasoned investor at Benchmark warns that the AI boom may be inflating prices beyond fundamentals, signaling a comi...
PI traders faced renewed selling pressure this week, driving PI below key thresholds. The market now tests 0.15 suppo...
Ecopetrol sits at the intersection of commodity pricing, currency risk, and refining margins. This guide breaks down ...
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Volatility persists into March 2026, prompting a new, diversified approach to cash flow. A four-ETF plan could target...
Chipotle’s stock rebound from a recent malaise is taking shape as pricing discipline and menu changes attract more di...
Could 2026 bring a surprise policy pivot? This guide explains why the Fed might hike instead of cutting, how that sce...
An executive sale of shares often sparks questions. This article unpacks what cheesecake factory sells $328000 means ...